Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-Incisional Multimodal Injection in Femur Fractures
NCT02793947Phase 4Completed
- Sponsor
- University of Iowa
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine, morphine and epinephrine in postoperative pain (2 arms), sponsored by University of Iowa. Primary endpoint: Visual Analog Scale Pain Assessment at 48 hours. Started May 2015; status: completed.
02
Drugs
ropivacainemorphineepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02793947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02793947.